Monthly Archives: September 2017

CAR-T Special report by BioPharma

  Excellent review by BIOPHARMA Reporter. Not to be missed.     Breaking News on Biopharmaceutical Development & Manufacturing     01-Sep-2017 State of the CAR-T special edition – Novartis' Kymriah approved in US This week the US FDA approved Novartis' chimeric antigen receptor (CAR) T cell therapy Kymriah marking a historic milestone in the […]

read more